Manganese-Doped Mesoporous Magnetic Nanocarriers for Cancer Treatment
Source abstract
Abstract
To achieve maximum curative effects and minimize side effects in trimodal synergistic cooperative tumor therapies, we propose a strategy of photothermal (PTT)-chemodynamic (CDT)-coordinated drug chemotherapy (DT) trimodal synergistic therapy. We designed a multifunctional manganese-doped mesoporous magnetic nanodrug carrier (NH 2 -MMNPs), which was equipped with pullulan oxide to form Schiff base bonds upon loading doxorubicin (DOX), thus creating an oMMNPs/DOX nanoplatform. This nanoplatform exhibits excellent controlled drug release, satisfactory photothermal conversion efficiency under NIR (808 nm) irradiation, good biodegradability, and targeted drug delivery capabilities. It also produces Fenton-like Mn 2+ in response to the highly expressed glutathione (GSH) in the tumor microenvironment, thereby generating chemodynamic therapy. The oMMNPs/DOX demonstrated remarkable killing efficacy in HeLa and MCF-7 cancer cell cultures and reached 84.1% tumor suppression in vivo. The in vitro and in vivo results confirm that this theranostic nanoplatform exhibits excellent biocompatibility and anticancer effects. Therefore, oMMNPs/DOX have potential utility as a magnetically targeted and pH/GSH/NIR triple-triggered drug carrier for synergistic PTT/CDT/DT therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Shanxi Medical University, Taiyuan 030001, China
Department of Chemistry, School of Basic Medical Science, Shanxi Medical University, Taiyuan 030001, China
Funding
National College Students Innovation and Entrepreneurship Training Program · Natural Science Foundation of Shanxi Province · Shanxi Medical University · Shanxi Scholarship Council of China
References (51)
Show source-provided references
1. 10.1021/acsanm.3c0510010.1021/acsanm.3c05100 ↗
2. 10.1016/j.cell.2023.02.01410.1016/j.cell.2023.02.014 ↗
3. 10.1021/acsanm.3c0459610.1021/acsanm.3c04596 ↗
4. 10.1016/j.actbio.2022.03.00110.1016/j.actbio.2022.03.001 ↗
5. 10.1021/acsanm.3c0120710.1021/acsanm.3c01207 ↗
6. 10.1038/s41467-023-42740-210.1038/s41467-023-42740-2 ↗
7. 10.1021/acsami.2c1966710.1021/acsami.2c19667 ↗
8. 10.1021/acsanm.3c0222310.1021/acsanm.3c02223 ↗
9. 10.1021/acsnano.1c0853610.1021/acsnano.1c08536 ↗
10. 10.1039/D1MA00646K10.1039/D1MA00646K ↗
11. 10.1016/j.ccr.2022.21497710.1016/j.ccr.2022.214977 ↗
12. 10.1039/D3NR02155F10.1039/D3NR02155F ↗
13. 10.1016/j.jinorgbio.2019.11088710.1016/j.jinorgbio.2019.110887 ↗
14. 10.1039/D0NR03135F10.1039/D0NR03135F ↗
15. 10.1021/jacs.9b1287310.1021/jacs.9b12873 ↗
16. 10.1021/acsanm.3c0439210.1021/acsanm.3c04392 ↗
17. 10.1021/jacs.6b0429910.1021/jacs.6b04299 ↗
18. 10.1016/j.ijbiomac.2019.12.26510.1016/j.ijbiomac.2019.12.265 ↗
19. 10.1002/smll.20190224210.1002/smll.201902242 ↗
20. 10.1007/s10853-019-03325-x10.1007/s10853-019-03325-x ↗
21. 10.1016/j.ijbiomac.2022.12.04010.1016/j.ijbiomac.2022.12.040 ↗
22. 10.1021/acs.biomac.3c0012710.1021/acs.biomac.3c00127 ↗
23. 10.1016/j.cej.2024.14861810.1016/j.cej.2024.148618 ↗
24. 10.1021/acsami.8b1795810.1021/acsami.8b17958 ↗
25. 10.1039/C8TB02663G10.1039/C8TB02663G ↗
26. 10.1016/j.ijbiomac.2023.12467310.1016/j.ijbiomac.2023.124673 ↗
27. 10.1016/j.mtbio.2023.10092510.1016/j.mtbio.2023.100925 ↗
28. 10.1016/j.biomaterials.2018.02.02910.1016/j.biomaterials.2018.02.029 ↗
29. 10.1016/j.jddst.2020.10178210.1016/j.jddst.2020.101782 ↗
30. 10.1016/j.colsurfb.2020.11127410.1016/j.colsurfb.2020.111274 ↗
31. 10.1016/j.jcis.2018.10.05610.1016/j.jcis.2018.10.056 ↗
32. 10.1002/anie.20171202710.1002/anie.201712027 ↗
33. 10.1016/j.jinorgbio.2021.11155810.1016/j.jinorgbio.2021.111558 ↗
34. 10.1016/j.ceramint.2020.01.13510.1016/j.ceramint.2020.01.135 ↗
35. 10.2147/IJN.S30626910.2147/IJN.S306269 ↗
36. 10.1002/adfm.20160331510.1002/adfm.201603315 ↗
37. 10.1063/1.491925010.1063/1.4919250 ↗
38. 10.1016/j.snb.2018.08.11810.1016/j.snb.2018.08.118 ↗
39. 10.1021/acsami.0c0838910.1021/acsami.0c08389 ↗
40. 10.1016/j.msec.2019.11025610.1016/j.msec.2019.110256 ↗
41. 10.3788/co.20181103.042010.3788/co.20181103.0420 ↗
42. 10.1016/j.jcou.2018.03.01410.1016/j.jcou.2018.03.014 ↗
43. 10.1039/c1cp21366k10.1039/c1cp21366k ↗
44. 10.1002/anie.20140271010.1002/anie.201402710 ↗
45. 10.1016/j.addr.2022.11448410.1016/j.addr.2022.114484 ↗
46. 10.1016/j.msec.2021.11250410.1016/j.msec.2021.112504 ↗
47. 10.1016/j.mtcomm.2021.10301010.1016/j.mtcomm.2021.103010 ↗
48. 10.1016/j.jddst.2021.10232710.1016/j.jddst.2021.102327 ↗
49. 10.1002/advs.20220366910.1002/advs.202203669 ↗
50. 10.1007/s11051-022-05498-010.1007/s11051-022-05498-0 ↗
51. 10.1039/C6NR07542H10.1039/C6NR07542H ↗